Greatness comes in many forms. There are truly some extraordinary people in todays society, but they’re unfortunately unknown. These people work to serve mankind, and they have come op with some great solutions to go about doing this. Dr. Clay Siegall is no exception to the rule. He is one of the most educated and well-respected beings in cancer research. His professional career extends back for over 20 years, and he has worked for many prominent medical industry names. This includes the National Institute of Health, the National Cancer Institute and Bristol Myers Squibb. He is also the president, founder and chief executive officer of Seattle Genetics.
Antibody-based therapies are the name of the game, and these advanced medications have produced some amazing results when it comes to fighting cancer. Their capabilities are extremely efficient because they attach themselves to cancerous cells in the body. After attaching, these medications deliver a cell-killing blow, all while bypassing the good cells in the body. No other cancer fighting medication can compete with this innovation. Siegall has stated that he didn’t get into cancer research until studying in college. At the time, he was majoring in Zoology and this shift in priorities has been a welcomed benefit to many people. Cancer has a history of sickness, amputation, radical surgery and death. “There had to be a better way,” said Siegall. With his strong passion, determination and perseverance, Siegall has helped to save many lives.
The company earns capital through a number of ways, which incudes licensing of technologies, selling its own proprietary drugs and through production partnerships. He has also stated that the company didn’t start making big profits until after it received its IPO. Siegall does so much here, and he applies the best principles. Rigorous research, drug development and scientific innovation. All in all, Dr. Clay Siegall is an extraordinary man with a heart of gold.